Cipla | CIPLA - Gewinn Vor Steuern

Aktienkurs
1,220.60
Täglich Wechseln
-35.80 -2.85%
Monatlich
-8.00%
Jährlich
-19.91%
Q1 Prognose
1,230.90




Gewinn Vor Steuern Veränderung Datum
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
Bio Path USD -4.6M 1.74M 2025-06
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cara Therapeutics USD -4.91M 3.17M 2025-03
Cipla INR 11.69B 6.85B 2025-12
Dr.Reddys Laboratories INR 15.68B 2.38B 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Immunic USD -21.38M 8.2M 2024-06
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sun Pharmaceuticals INR 41.68B 9.95B 2025-09
TherapeuticsMD USD -1.05M 241K 2024-06
UPL INR 7.27B 850M 2025-12